HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

LY 353381 (LY353381)

structure in first source
Also Known As:
LY353381; 4'F-DMA; LY-353381; LY353381hydrochloride; arzoxifene
Networked: 56 relevant articles (5 outcomes, 20 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Bolton, Judy L: 4 articles (01/2009 - 02/2005)
2. Thatcher, Gregory R J: 4 articles (01/2009 - 02/2005)
3. Sporn, Michael B: 4 articles (10/2006 - 10/2002)
4. Risingsong, Renee: 3 articles (10/2006 - 10/2002)
5. Suh, Nanjoo: 3 articles (10/2006 - 10/2002)
6. Williams, Charlotte R: 3 articles (10/2006 - 10/2002)
7. Jordan, V Craig: 2 articles (05/2013 - 01/2006)
8. Amewou-Atisso, Messan: 2 articles (07/2012 - 02/2011)
9. Cox, David A: 2 articles (07/2012 - 01/2012)
10. Cummings, Steven R: 2 articles (07/2012 - 02/2011)

Related Diseases

1. Breast Neoplasms (Breast Cancer)
2. Osteoporosis
3. Neoplasms (Cancer)
4. Endometrial Neoplasms (Endometrial Cancer)
5. Postmenopausal Osteoporosis

Related Drugs and Biologics

1. Raloxifene Hydrochloride (Evista)
2. Selective Estrogen Receptor Modulators (SERM)
3. Tamoxifen
4. Methylnitrosourea (N-Methyl-N-nitrosourea)
5. Carcinogens
6. LY 353381 (LY353381)
7. Estrogens (Estrogen)
8. benzothiophene
9. Lasofoxifene
10. Estrogen Receptors

Related Therapies and Procedures

1. Chemoprevention
2. Drug Therapy (Chemotherapy)
3. Therapeutics
4. Time-to-Treatment
5. Hormone Replacement Therapy (Therapy, Hormone Replacement)